Abu Dhabi-Mubasher: Gulf Pharmaceutical Industries (Julphar) is expected to begin its operations in the Saudi Arabia oral preparations facility by the end of 2016, said Julphar’s chairman Faisal bin Saqr Al Qasimi, according to Emirates News Agency (WAM).
It is noteworthy that Julphar is listed on Abu Dhabi Securities Exchange.
Julphar’s Saudi Arabia facility has a capital standing at AED 300 million, becoming the first UAE-Saudi investment partnership in the pharmaceutical industry.
